Literature DB >> 32703111

Deletion of ubiquitin ligase Nedd4l exacerbates ischemic brain damage.

TaeHee Kim1, Anil K Chokkalla1,2, Raghu Vemuganti1,2,3.   

Abstract

Ubiquitination by Nedd4 (neuronally expressed developmentally downregulated 4) family of HECT type E3 ligases plays a key role in degrading misfolded and damaged proteins, and its disruption leads to neurodegeneration. Parkinson's disease-causing protein α-Synuclein (α-Syn) is ubiquitinated by the Nedd4 family and degraded by endosomes. Nedd4l is the only Nedd4 homolog that showed upregulation in post-stroke surviving cortical neurons where it correlated with neuroprotection. We tested the role of Nedd4l after stroke by subjecting the Nedd4l-/- mice to transient middle cerebral artery occlusion. Focal ischemia significantly increased Nedd4l expression and poly-ubiquitinated α-Syn levels, and knockout of Nedd4l reduced post-ischemic poly-ubiquitinated α-Syn that is majorly located in the peri-infarct neurons. Co-immunoprecipitation further shows that focal ischemia enhances the α-Syn-Nedd4l interaction resulting in increased ubiquitination of α-Syn. Nedd4l knockout mice (n = 7 mice/group) showed exacerbated post-ischemic motor dysfunction manifested by decreased time on the rotarod and increased number of foot faults, and significantly increased ischemic brain damage. This suggests that Nedd4l might be a potential therapeutic target to minimize α-Syn-mediated toxicity after cerebral ischemia.

Entities:  

Keywords:  Neurodegeneration; post-translational modifications; protein aggregation; stroke; ubiquitination

Year:  2020        PMID: 32703111      PMCID: PMC8054722          DOI: 10.1177/0271678X20943804

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  20 in total

Review 1.  Protein aggregation in Parkinson's disease.

Authors:  V Gundersen
Journal:  Acta Neurol Scand Suppl       Date:  2010

2.  Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway.

Authors:  George K Tofaris; Hyoung Tae Kim; Raphael Hourez; Jin-Woo Jung; Kwang Pyo Kim; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-27       Impact factor: 11.205

3.  Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage.

Authors:  TaeHee Kim; Suresh L Mehta; Balarama Kaimal; Kirsten Lyons; Robert J Dempsey; Raghu Vemuganti
Journal:  J Neurosci       Date:  2016-06-29       Impact factor: 6.167

4.  The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein.

Authors:  TaeHee Kim; Suresh L Mehta; Kahlilia C Morris-Blanco; Anil K Chokkalla; Bharath Chelluboina; Mary Lopez; Ruth Sullivan; Hung Tae Kim; Thomas D Cook; Joo Yong Kim; HwuiWon Kim; Chanul Kim; Raghu Vemuganti
Journal:  Sci Signal       Date:  2018-12-11       Impact factor: 8.192

5.  A semiautomated method for measuring brain infarct volume.

Authors:  R A Swanson; M T Morton; G Tsao-Wu; R A Savalos; C Davidson; F R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  1990-03       Impact factor: 6.200

Review 6.  α-Synuclein ubiquitination and novel therapeutic targets for Parkinson's disease.

Authors:  Ruth Rott; Raymonde Szargel; Vered Shani; Sleman Bisharat; Simone Engelender
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

7.  Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease.

Authors:  Sian E Davies; Penelope J Hallett; Thomas Moens; Gaynor Smith; Emily Mangano; Hyoung Tae Kim; Alfred L Goldberg; Ji-Long Liu; Ole Isacson; George K Tofaris
Journal:  Neurobiol Dis       Date:  2013-12-31       Impact factor: 5.996

8.  Long Noncoding RNA FosDT Promotes Ischemic Brain Injury by Interacting with REST-Associated Chromatin-Modifying Proteins.

Authors:  Suresh L Mehta; TaeHee Kim; Raghu Vemuganti
Journal:  J Neurosci       Date:  2015-12-16       Impact factor: 6.167

9.  Loss of NEDD4 contributes to RTP801 elevation and neuron toxicity: implications for Parkinson's disease.

Authors:  Mercè Canal; Núria Martín-Flores; Leticia Pérez-Sisqués; Joan Romaní-Aumedes; Bekir Altas; Heng-Ye Man; Hiroshi Kawabe; Jordi Alberch; Cristina Malagelada
Journal:  Oncotarget       Date:  2016-09-13

10.  Ubiquitination of alpha-synuclein filaments by Nedd4 ligases.

Authors:  Thomas Mund; Masami Masuda-Suzukake; Michel Goedert; Hugh R Pelham
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

View more
  4 in total

1.  E3 ubiquitin ligase Nedd4-2 exerts neuroprotective effects during endoplasmic reticulum stress.

Authors:  Daphne E Lodes; Jiuhe Zhu; Nien-Pei Tsai
Journal:  J Neurochem       Date:  2021-12-29       Impact factor: 5.372

2.  Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma.

Authors:  Liping Lin; Xuan Wu; Yuanxue Jiang; Caijiu Deng; Xi Luo; Jianjun Han; Jiazhu Hu; Xiaolong Cao
Journal:  PeerJ       Date:  2022-05-24       Impact factor: 3.061

3.  RNA sequencing-based identification of the regulatory mechanism of microRNAs, transcription factors, and corresponding target genes involved in vascular dementia.

Authors:  Kaiyue Zhao; Li Zeng; Zhongdi Cai; Mimin Liu; Ting Sun; Zhuorong Li; Rui Liu
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

4.  Infantile spasms-linked Nedd4-2 mediates hippocampal plasticity and learning via cofilin signaling.

Authors:  Kwan Young Lee; Jiuhe Zhu; Cathryn A Cutia; Catherine A Christian-Hinman; Justin S Rhodes; Nien-Pei Tsai
Journal:  EMBO Rep       Date:  2021-08-03       Impact factor: 9.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.